Pfizer

Latest Stories

COVID-19 vaccine manufacturer Moderna has filed lawsuits against both Pfizer and BioNTech over alleged patent violations pertaining to its mRNA technology.

COVID-19 vaccine manufacturer Moderna has filed lawsuits against both Pfizer and BioNTech over alleged patent violations pertaining to its mRNA technology.

BY JOE PRICE

Moderna Files Lawsuit Against Pfizer and BioNTech Over Alleged COVID-19 Vaccine Patent Violations

Next week, an FDA committee is slated to hold a discussion event focused on whether or not to modify the composition of current COVID-19 vaccines.

Next week, an FDA committee is slated to hold a discussion event focused on whether or not to modify the composition of current COVID-19 vaccines.

BY TRACE COWEN

Pfizer and BioNTech Say Omicron-Adapted Vaccines Show ‘High Immune Response’ Against Variant

On the track "Savior," Kendrick also reflects on a scenario in which a vaccine-averse Christian has a change of heart after catching COVID-19.

On the track "Savior," Kendrick also reflects on a scenario in which a vaccine-averse Christian has a change of heart after catching COVID-19.

BY TRACE COWEN

Kendrick Lamar Mentions Kyrie Irving's COVID Vaccine Controversy on 'Mr. Morale & the Big Steppers' Track "Savior"

Albert Bourla said that a fourth vaccine dose may be needed when it comes to newer COVID variants and that Pfizer will be submitting data regarding one.

Albert Bourla said that a fourth vaccine dose may be needed when it comes to newer COVID variants and that Pfizer will be submitting data regarding one.

BY BRENTON BLANCHET

Pfizer CEO Says 4th COVID-19 Vaccine Dose Will Be Needed

The clinical study, announced Tuesday, will see Pfizer and BioNTech analyzing a vaccine candidate that specifically targets the pandemic-extending variant.

The clinical study, announced Tuesday, will see Pfizer and BioNTech analyzing a vaccine candidate that specifically targets the pandemic-extending variant.

BY TRACE COWEN

Pfizer Starts Clinical Study for Omicron-Focused Version of COVID-19 Vaccine

Pfizer CEO Albert Bourla also cautioned that only having two vaccine doses is "not enough" when it comes to now the Omicron variant is behaving.

Pfizer CEO Albert Bourla also cautioned that only having two vaccine doses is "not enough" when it comes to now the Omicron variant is behaving.

BY TRACE COWEN

Pfizer CEO on When to Expect Omicron Vaccine, Says Two Doses of Current Version ‘Not Enough’

A study of Pfizer’s new COVID pill Paxlovid confirmed that the antiviral medication helps prevent severe disease in high-risk individuals sick with the virus.

A study of Pfizer’s new COVID pill Paxlovid confirmed that the antiviral medication helps prevent severe disease in high-risk individuals sick with the virus.

BY MACKENZIE CUMMINGS-GRADY

New Study Shows How Effective Pfizer COVID Pill Is

On Wednesday, Pfizer said a booster shot of its COVID-19 vaccine could provide increased protection against the recently discovered Omicron variant.

On Wednesday, Pfizer said a booster shot of its COVID-19 vaccine could provide increased protection against the recently discovered Omicron variant.

BY JOE PRICE

Pfizer Says COVID-19 Vaccine Booster Shot Improves Protection Against Omicron Variant

Pfizer CEO Albert Bourla called those who are spreading misinformation about the COVID-19 vaccines "criminals," and accused them of costing lives.

Pfizer CEO Albert Bourla called those who are spreading misinformation about the COVID-19 vaccines "criminals," and accused them of costing lives.

BY BRENTON BLANCHET

Pfizer CEO Calls People Who Are Spreading Vaccine Misinformation ‘Criminals’

Pfizer says its new COVID-19 antiviral pill can reduce the risks of hospitalization or death by 89 percent in high-risk adults. It has yet to be approved.

Pfizer says its new COVID-19 antiviral pill can reduce the risks of hospitalization or death by 89 percent in high-risk adults. It has yet to be approved.

BY TARAMHDVN

Pfizer Says Its Antiviral COVID-19 Pill Curbs Hospitalization or Death by 89 Percent